Zander, T., Scheffler, M., Nogova, L., Kobe, C., Engel-Riedel, W., Hellmich, M., et al. (2011). Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. Journal of Clinical Oncology, 29(13), 1701-1708. doi:10.1200/JCO.2010.32.4939.